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Genec Screening 
As genomic medicine advances, screening the 
whole populaon for genec condions is now 
possible. However, lile is known about what 
people living with bleeding disorders think 
about screening, nor the social and ethical 
issues it raises.
In 2017, researchers Drs Felicity Boardman, 
Rachel Hale and Philip Young began to explore 
this topic, using interviews and a survey. With 
The Haemophilia Society’s support, 22 people 
were interviewed and 415 people completed 
a screening atudes survey, all of whom 
had a bleeding disorder or were relaves of 
someone who did.
Mixed views
The results showed a mix of perspecves 
towards both screening and bleeding 
disorders. A minority of parcipants described 
bleeding disorders as debilitang and 
burdensome; however most considered them 
manageable, parcularly when well controlled. 
The most obvious diīerences in atude were 
between older adults with haemophilia 
(many of whom had been exposed to 
blood-borne viruses) and younger parcipants, 
many of whom are beneĮng from treatment 
improvements, parcularly prophylaxis. 
Concerns around screening
Both survey and interview parcipants 
were quite crical of the idea of populaon 
screening for bleeding disorders, the major 
concern being that it might lead to pregnancy 
terminaons. Instead, they emphasised the 
need for early diagnosis and treatment, with 
77% of survey parcipants believing that 
newborn screening was the most acceptable 
screening programme. The prospect of 
pregnancy or pre-pregnancy screening 
generated less support, at 59% and 57% 
respecvely. 
Given the negave atudes towards 
terminaon, it was inially surprising that 
pregnancy screening was viewed slightly more 
favourably than pre-pregnancy. However, 
further analysis revealed that this was because 
parcipants believed the informaon could 
assist preparaon for the birth of a child with 
haemophilia, rather than inform a terminaon 
decision. Indeed, 90% of survey parcipants 
regarded terminaon for haemophilia as 
ethically unacceptable.   
Overall, bleeding disorders were largely 
viewed as liveable condions. Screening 
was supported when used for informaon, 
although fears emerged about the accuracy 
and quality of that informaon, parcularly 
when the general public were viewed as 
largely ignorant of bleeding disorders. 
High quality informaon, early diagnosis, 
educaon and access to treatment (especially 
prophylaxis) were considered the most 
important goals of any screening programme, 
rather than prevenon per se. 
What will happen to the results?
These results will be prepared for a report to 
the UK Naonal Screening Commiee and 
also distributed to academics, researchers and 
clinicians, giving them an overview of the main 
concerns that families aīected by bleeding 
disorders have about screening.
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